DRESSING,AMD FOAM BORDER 1.75IN X 3.25IN K#55523BAMD

Known as: DRESSING,AMD FOAM 1.75X3.25IN K#55523 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2017
051019962017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The clinical hallmark of the early stage of AMD is drusen, which are yellowish deposits at the level of the RPE. Focal RPE… (More)
Is this relevant?
2017
2017
PURPOSE To assess the prevalence of vitreomacular adhesion (VMA) in consecutive naïve eyes diagnosed with exudative age-related… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2016
2016
PURPOSE To assess the effect of availability of anti-vascular endothelial growth factor (VEGF) therapy on mortality and… (More)
Is this relevant?
Review
2016
Review
2016
TOPIC To review the role of anatomic endpoints in clinical trials for the study of nonexudative age-related macular degeneration… (More)
Is this relevant?
Review
2011
Review
2011
Aims: To evaluate a new polyhexamethylene biguanide (PHMB) foam dressing for inclusion in the specialist dressing section of a… (More)
  • table 1
  • table 2
Is this relevant?
2010
2010
PURPOSE To investigate the relationship between known risk factors for age-related macular degeneration (AMD) progression and… (More)
Is this relevant?
2008
2008
OBJECTIVE To describe the relationship of systemic inflammatory disease, complement factor H (CFH) Y402H (1277T-->C) genotype… (More)
Is this relevant?
1999
1999
OBJECTIVE This pilot study collected preliminary information on the effectiveness and safety of infrared (810-nm) diode laser… (More)
Is this relevant?
1998
1998
OBJECTIVE The aim of this study was to identify subgroups of patients for whom the interactions among clinical, socioeconomic… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
PURPOSE The authors describe the clinical characteristics of a group of patients with age-related macular degeneration (AMD… (More)
Is this relevant?